Table 1 Definitions of survival endpoints
From: Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis
Endpoints | Definition |
|---|---|
Overall survival | Entry into study until death as a result of any cause |
Progression-free survival | Entry into study until lymphoma progression or death as a result of any cause |
Event-free survival | Entry into study until any treatment failure including lymphoma progression, or discontinuation of treatment for any reason including death |
Lymphoma-specific survival | Entry into study until time to death as a result of lymphoma |
Time-to-progression | Entry into study until time to lymphoma progression or death as a result of lymphoma |